AM-9022 | Interleukin Related interleukin-related.com

Product Name :
AM-9022

Search keywords :
AM-9022

drugId :
null

Target Vo:
Kinesin-like protein KIF18A

Target Vo Short Name :
KIF18A

Moa_Name:
Kinesin-like protein KIF18A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Amgen Research Inc

Active Company_Name :
Amgen Research Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RASA1 Antibody
Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
beta III Tubulin Antibody: beta III Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta III Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts